| Financial Year |
March 31 2023 |
| Monetary Funds |
1,558,480,002.29 |
| Held-for-trading Financial Assets |
20,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,042,279,563.45 |
| Advances to Suppliers |
98,135,476.61 |
| Other Receivables |
3,048,920.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,221,005,055.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
70,447,827.17 |
| Total Current Assets |
4,048,558,086.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
158,863,014.90 |
| Investment Properties |
-- |
| Fixed Assetes |
5,961,761,316.81 |
| Under-construction Projects |
803,789,907.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
281,474,945.73 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
272,932,073.38 |
| Other Non-Current Assets |
11,417,803.75 |
| Sub-Total of Non-Current Assets |
7,504,709,077.50 |
| Total Assets |
11,553,267,164.26 |
| Short-Term Loans |
804,667,411.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
252,000,000.00 |
| Accounts Payable |
786,186,973.12 |
| Accounts Received In Advance |
31,188,152.31 |
| Employee Compensation Payable |
10,919,469.92 |
| Taxes Payable |
17,811,288.11 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
19,692,001.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,063,571,719.13 |
| Other Current Liabilities |
5,466,164.03 |
| Sub-Total of Current Liabilities |
3,033,550,595.22 |
| Long-term Loans |
2,789,188,835.65 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
119,849,089.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,013,044,377.07 |
| Total Liabilities |
6,046,594,972.29 |
| Paid-In Capital(Or Share Stock) |
1,466,727,778.00 |
| Capital Surplus |
2,485,925,990.58 |
| Surplus Reserve |
379,524,120.32 |
| LESS:Treasury Stock |
150,999,551.25 |
| Undistributed Profits |
1,325,493,854.32 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,506,672,191.97 |
| Owner's Equity（Stockholder's Equity） |
5,506,672,191.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,553,267,164.26 |
